…..then the combined minds of the National Institutes of Health, ten major drug companies, and seven nonprofit groups ought to be able to make some progress. This unique collaboration plans to target treatment development for lupus, rheumatoid arthritis, Alzheimer’s, and Type 2 diabetes over the next 5 years. The group were compelled to cooperation for different reasons: major drug companies have invested and lost in many promising treatments while other groups are inundated in biological data. Hopefully, by their powers combined, effective treatment option for these debilitating diseases.
(NIH Clinical Research Center from Wikicommons)
Read more about why these disorders were selected, the reasons for the joint effort, and more at the New York Times: http://www.nytimes.com/2014/02/05/health/nih-joins-drug-makers-and-nonprofits-on-stubborn-diseases.html?hp&_r=1.
Sign-Up For The Latest From TGNR
Entertainment & Arts3 months ago
10 Things Star Trek: Discovery Season 2 Must Do to Avoid Epic Failure
Entertainment & Arts2 months ago
The Man in the High Castle Universe: How the Axis Won WW2
History5 months ago
The Forgotten Declaration of Independence Signers Who Lost Everything for Signing
Health and Fitness6 months ago
BMI: Everything You Need to Know About Body Mass Index
Sunday Brunch4 weeks ago
The New Quartz App: Uzabase’s Bet on the Future of News on Social Media